These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32407280)

  • 1. On the Possible Relevance of Bottom-up Pathways in the Pathogenesis of Alzheimer's Disease.
    Leblhuber F; Steiner K; Geisler S; Fuchs D; Gostner JM
    Curr Top Med Chem; 2020; 20(15):1415-1421. PubMed ID: 32407280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knock-on effect of periodontitis to the pathogenesis of Alzheimer's disease?
    Leblhuber F; Huemer J; Steiner K; Gostner JM; Fuchs D
    Wien Klin Wochenschr; 2020 Sep; 132(17-18):493-498. PubMed ID: 32215721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
    Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
    Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic Supplementation in Patients with Alzheimer's Dementia - An Explorative Intervention Study.
    Leblhuber F; Steiner K; Schuetz B; Fuchs D; Gostner JM
    Curr Alzheimer Res; 2018; 15(12):1106-1113. PubMed ID: 30101706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tryptophan degradation and immune activation in Alzheimer's disease.
    Widner B; Leblhuber F; Walli J; Tilz GP; Demel U; Fuchs D
    J Neural Transm (Vienna); 2000; 107(3):343-53. PubMed ID: 10821443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive deterioration in Alzheimer's disease is accompanied by increase of plasma neopterin.
    Blasko I; Knaus G; Weiss E; Kemmler G; Winkler C; Falkensammer G; Griesmacher A; Würzner R; Marksteiner J; Fuchs D
    J Psychiatr Res; 2007 Oct; 41(8):694-701. PubMed ID: 16542679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune activation in patients with Alzheimer's disease is associated with high serum phenylalanine concentrations.
    Wissmann P; Geisler S; Leblhuber F; Fuchs D
    J Neurol Sci; 2013 Jun; 329(1-2):29-33. PubMed ID: 23566485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's Disease Microbiome Is Associated with Dysregulation of the Anti-Inflammatory P-Glycoprotein Pathway.
    Haran JP; Bhattarai SK; Foley SE; Dutta P; Ward DV; Bucci V; McCormick BA
    mBio; 2019 May; 10(3):. PubMed ID: 31064831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.
    Han P; Caselli RJ; Baxter L; Serrano G; Yin J; Beach TG; Reiman EM; Shi J
    JAMA Neurol; 2015 Mar; 72(3):333-9. PubMed ID: 25599520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer's disease.
    Brosseron F; Traschütz A; Widmann CN; Kummer MP; Tacik P; Santarelli F; Jessen F; Heneka MT
    Alzheimers Res Ther; 2018 Feb; 10(1):25. PubMed ID: 29482610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer's disease dementia in mild cognitive impairment.
    Baldeiras I; Santana I; Leitão MJ; Gens H; Pascoal R; Tábuas-Pereira M; Beato-Coelho J; Duro D; Almeida MR; Oliveira CR
    Alzheimers Res Ther; 2018 Mar; 10(1):33. PubMed ID: 29558986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kynurenine Pathway Metabolites in Alzheimer's Disease.
    Giil LM; Midttun Ø; Refsum H; Ulvik A; Advani R; Smith AD; Ueland PM
    J Alzheimers Dis; 2017; 60(2):495-504. PubMed ID: 28869479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.
    Harris SA; Harris EA
    J Alzheimers Dis; 2015; 48(2):319-53. PubMed ID: 26401998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.
    Lueg G; Gross CC; Lohmann H; Johnen A; Kemmling A; Deppe M; Groger J; Minnerup J; Wiendl H; Meuth SG; Duning T
    Neurobiol Aging; 2015 Jan; 36(1):81-9. PubMed ID: 25277040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Mathys J; Gholamrezaee M; Henry H; von Gunten A; Popp J
    Exp Gerontol; 2017 Dec; 100():45-53. PubMed ID: 29054536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.
    Meyer PF; Savard M; Poirier J; Labonté A; Rosa-Neto P; Weitz TM; Town T; Breitner J; ;
    J Alzheimers Dis; 2018; 63(2):577-590. PubMed ID: 29660934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.